v3.26.3
Fair Value Measurements - Roll Forward of Changes in Fair Value of Financial Liabilities Classified as Level 3 (Details) - Level 3 [Member]
$ in Thousands
9 Months Ended
Sep. 30, 2026
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning balance at December 31, 2025 $ 0
Contingent Consideration Liabilities recognized upon acquisition of Mantle Therapeutics Inc. on September 29, 2026 1,267
Change in estimated fair value since acquisition 0
Ending balance at September 30, 2026 $ 1,267